Furin targeted drug delivery for treatment of rhabdomyosarcoma in a mouse model.

Furin targeted drug delivery for treatment of rhabdomyosarcoma in a mouse model.
复制标题

DOI:
10.1371/journal.pone.0010445
复制
发表时间:
2010-05-03
期刊:
影响因子:
3.7
通讯作者:
Bernasconi M
Bernasconi M
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Hajdin K;D'Alessandro V;Niggli FK;Schäfer BW;Bernasconi M

文献摘要

参考文献

被引文献

相似文献

横纹肌肉瘤(RMS)是儿童最常见的软组织肉瘤。通过肿瘤靶向给药来提高治疗效果和减少副作用将是可取的。通过噬菌体展示的环状随机多肽文库的筛选,我们在体内外筛选出与RMS有较强亲和力的多肽。经丙氨酸扫描鉴定,其最小结合基序为Arg-X-(Arg/Lys)(Arg/Lys),提示靶向受体为原蛋白转换酶(PC)。所有PC在RMS活检和细胞系中的表达谱显示,膜结合的Furin和PC7的表达水平一致高。亲和层析证实了RMS-P3多肽与呋喃的直接结合,并得到活性和共定位研究的支持。与阿霉素单独治疗相比,阿霉素与靶向多肽联合治疗小鼠RMS的疗效提高了两倍。我们的发现表明,表面-呋喃结合是治疗细胞渗透的新机制,需要进一步研究。此外,这项工作证明了在肿瘤中特异性靶向膜结合的Furin是可能的,并提示RMS和其他肿瘤可能受益于原蛋白转换酶靶向药物输送。
Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children. Improvement of treatment efficacy and decreased side effects through tumor-targeted drug delivery would be desirable. By panning with a phage-displayed cyclic random peptide library we selected a peptide with strong affinity for RMS in vitro and in vivo. The peptide minimal binding motif Arg-X-(Arg/Lys)(Arg/Lys) identified by alanine-scan, suggested the target receptor to be a proprotein convertase (PC). Expression profiling of all PCs in RMS biopsies and cell lines revealed consistent high expression levels for the membrane-bound furin and PC7. Direct binding of RMS-P3 peptide to furin was demonstrated by affinity chromatography and supported by activity and colocalization studies. Treatment of RMS in mice with doxorubicin coupled to the targeting peptide resulted in a two-fold increase in therapeutic efficacy compared to doxorubicin treatment alone. Our findings indicate surface-furin binding as novel mechanism for therapeutic cell penetration which needs to be further investigated. Furthermore, this work demonstrates that specific targeting of membrane-bound furin in tumors is possible for and suggests that RMS and other tumors might benefit from proprotein convertases targeted drug delivery.
DOI: 10.1158/0008-5472.can-07-6752
发表时间: 2008-09-01
期刊: Cancer research
影响因子: 11.2
作者:
Fogal V;Zhang L;Krajewski S;Ruoslahti E
通讯作者: Ruoslahti E
DOI: 10.1016/s0002-9440(10)63838-2
发表时间: 2003-02-01
影响因子: 6
作者:
Bassi, DE;Mahloogi, H;Klein-Szanto, A
通讯作者: Klein-Szanto, A
DOI: 10.1634/theoncologist.10-7-518
发表时间: 2005-08-01
期刊: ONCOLOGIST
影响因子: 5.8
作者:
Breitfeld, PP;Meyer, WH
通讯作者: Meyer, WH
DOI: 10.1042/bj20021630
发表时间: 2003-07-15
影响因子: 4.1
作者:
Bergeron, E;Basak, A;Seidah, NG
通讯作者: Seidah, NG